I’m sensing a lot of unjustified doom and gloom from investors.

Legendary investor Jeremy Grantham recently told Bloomberg, “No one should invest in the US.”

I have great respect for the guy, but c’mon… he’s been predicting Armageddon for a decade straight.

And look at all these exciting breakthroughs going on…

1. AI will win the Nobel Prize.

The first week of October was Nobel Prize week. And of course, all the winners were super-smart humans.

I’m predicting humanity’s winning streak will soon end.

It’s only a matter of time before an artificial intelligence (AI) tool like ChatGPT makes a major medical breakthrough and wins the Nobel Prize for medicine. Give it three years, max.

Know what’s amazing? A mechanic can plug a cable into my car and instantly diagnose a problem. Yet a doctor will often put a human through a gauntlet of medical tests… and still not have the foggiest idea what’s wrong.

AI will help solve our medical riddles. It’s already made Nobel Prize-worthy breakthroughs.

In fact, AI recently gave a paralyzed woman named Ann her voice back.

AI “learned” her voice by listening to a single recording of her speaking at her wedding. Researchers built a system that synthesizes speech from Ann’s brain signals.

And she doesn’t sound like Stephen Hawking’s robot voice. Her voice sounds the same as it did before the injury!

Read that sentence again and tell me humans (plus AI) don’t rock!

And there’s plenty more where that came from.

Facebook founder “Zuck” just announced he’s footing the bill for a biotech supercomputer “to cure, prevent, or manage all diseases.” A bad time to be a disease; a great time to be alive.

As usual, Nvidia (NVDA) is a clear-cut winner here. There will be tens of millions of “AIs”... and Nvidia’s chips will power the lot.

Set your clocks: AI will win a Nobel Prize within three years.

2. This represents everything that’s right with America.

Forget the pyramids or the Colosseum.

The Las Vegas Sphere is the first wonder of our (digital) world.

Standing 350 feet tall and 500 feet wide, the world’s largest sphere is made up of 1.2 million hockey puck-sized LED lights. It’s basically a giant, ball-shaped screen.

The other night, it transformed into a Halloween pumpkin:

And oh yeah, there’s an 18,000-seater stadium inside the Sphere. Rock band U2 are rocking inside in the photo below.

I have no time for Bono, but wow… where can I buy tickets? Here’s the inside. Blew. My. Mind.

Source: CNN

This giant orb—plonked in the middle of the Nevada desert—symbolizes why our future will be better than you can possibly imagine.

I’m sure you’ve heard people complain America can’t build things anymore.

The Empire State Building was built in 400 days. Yet it’s been 15 years… and the high-speed rail line that’s supposed to connect San Francisco to LA can’t even get started.

Las Vegas’s Sphere is 10X more impressive than anything big tech built in the last decade.

It represents everything that’s “right” with America. A big, bold, ambitious project. It’s $2.3 billion well spent.

It’s a new era for America, friends. Elon Musk is building rockets to Mars. Florida has high-speed railways. New nuclear power plants? Check.

Next come the flying cars

This new era will throw up lots of exciting opportunities.

Did you know you can own a piece of the Sphere?

Sphere Entertainment (SPHR) isn’t good enough to make it into the Disruption Investor portfolio, but it could be a fun trade.

It’s clearly going to make millions of dollars selling ads. You can get your product on the orb for a cool $450,000/day. That works out to $165 million/year.

Why not put 100 bucks into SPHR and see where it is in a year?

3. Everybody does it, but no one talks about it.

I’m sure you’ve heard of the “wonder drug” Ozempic. It suppresses hunger… and helps folks lose weight in a hurry.

It’s flying off the shelves, and creator Novo Nordisk’s (NVO) stock is going vertical:

Ozempic has a good chance at being the most successful product in history. I wouldn’t be surprised if Novo Nordisk sells a trillion dollars’ worth of it.

Ozempic is like the new cocaine on Wall Street. Everybody does it, but no one talks about it.

Walmart (WMT), which sells hundreds of billions of dollars’ worth of groceries, says Ozempic is causing lower food sales.

Wow! I guarantee no analyst accounted for that in their price targets.

But Walmart will be fine… because its pharmacies have seen a 300% spike in Ozempic sales.

I’m not a fan of quick-fix pills. I won’t be an Ozempic customer.

But when I put my investor glasses on, I see opportunity.

Glance up at that chart of Novo Nordisk. You see how much wealth can quickly be created by making a blockbuster drug?

These days, 14 of the top 20 best-selling drugs in the world are biologics—medicines made from living things.

4. Dose of optimism…

One reason I quit corporate finance was because I had to sit at a desk all day.

I’m like an energetic kid who sits upside down watching TV. I like to move, to feel alive.

That’s why I own a standing desk. I work standing up to bring the energy… and live longer.

Recent studies show sitting is the new smoking. People who sit for eight hours a day with no exercise have a similar risk of dying as those who puff on cancer sticks!

Stand up. It might just save your life.

Stephen McBride

Chief Analyst, RiskHedge

To get more ideas like this sent straight to your inbox every Monday, Wednesday, and Friday, make sure to sign up for The RiskHedge Report, a free investment letter focused on profiting from disruption.

Expect smart insights and analysis on the latest breakthrough technologies, the big stories the mainstream media isn't reporting on, and much more... including actionable recommendations.

Click here to sign up.

© 2023 Copyright Stephen McBride - All Rights Reserved Disclaimer: The above is a matter of opinion provided for general information purposes only and is not intended as investment advice. Information and analysis above are derived from sources and utilising methods believed to be reliable, but we cannot accept responsibility for any losses you may incur as a result of this analysis. Individuals should consult with their personal financial advisors.

Only logged in users are allowed to post comments. Register/ Log in

The Market Oracle is a FREE Financial Markets Forecasting & Analysis web-site.
(c) 2005-2024 MarketOracle.co.uk (Market Oracle Ltd) - Market Oracle Ltd asserts copyright on all articles authored by our editorial team and all comments posted. Any and all information provided within the web-site, is for general information purposes only and Market Oracle Ltd do not warrant the accuracy, timeliness or suitability of any information provided on this site. nor is or shall be deemed to constitute, financial or any other advice or recommendation by us. and are also not meant to be investment advice or solicitation or recommendation to establish market positions. We do not give investment advice and our comments are an expression of opinion only and should not be construed in any manner whatsoever as recommendations to enter into a market position either stock, option, futures contract, bonds, commodity or any other financial instrument at any time. We recommend that independent professional advice is obtained before you make any investment or trading decisions. By using this site you agree to this sites Terms of Use. From time to time we promote or endorse certain products / services that we believe are worthy of your time and attention. In return for that endorsement and only in the cases where you purchase directly though us may we be compensated by the producers of those products.